Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2015

Conditions
Non-small-cell Lung Cancer
Interventions
DRUG

Chidamide

Given orally

DRUG

Paclitaxel

Given IV

DRUG

Carboplatin

Given IV

DRUG

Placebo

Given orally

Trial Locations (8)

82816

The Second People's Hospital of Sichuan, Chengdu

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

101149

Beijing Chest Hospital, Capital Medical University, Beijing

110001

The first Hospital of China Medical University, Shenyang

200030

Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai

210009

Jiangsu Cancer Hospital, Nanjing

300060

Tianjin Medical University Cancer Institute & Hospital, Tianjin

050011

Hebei Provincial Tumor Hospital, Shijiazhuang

Sponsors
All Listed Sponsors
lead

Chipscreen Biosciences, Ltd.

INDUSTRY

NCT01836679 - Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter